Syndax Pharmaceuticals will announce its third quarter 2026 financial results on November 2, 2026, followed by a conference call and webcast at 4:30 p.m. ET. The company, known for its cancer therapies including FDA-approved drugs Revuforj® and Niktimvo™, will provide a business update during the event. Investors can access the webcast via the company website, with a replay available for 90 days. This update is important as it offers insights into Syndax's progress and financial health amid ongoing clinical trials and commercial activities.
Syndax Pharmaceuticals' upcoming Q3 2026 financial results announcement provides timely context for healthcare market activity. For readers following health-sector stocks, here is Pluang's market snapshot as of Oct 26, 2026 18:11 WIB: out of 150 priced US health stocks, 82 rose and 35 fell. Notable moves include IMVT at USD 28.03 with a 1-day change of -1.34% and a typical hold time of 17 days, JNJ at USD 266.99 up 1.21% with a hold time of 130 days, and TNGX at USD 23.61 up 1.16% with a hold time of 2 days.
Smithfield Foods has created a $250,000 Future Leaders Scholarship program at Christopher Newport University to support eight incoming business students with $7,500 annual scholarships renewable for up to four years. The program aims to help local st...
E-Power Inc.'s joint venture, Sunrise Guizhou, received RMB 110 million of a planned RMB 200 million capital increase, raising its registered capital and valuing the company at RMB 2 billion post-money. The funds will support business expansion, R&D,...
AS Tallinna Sadam has signed a €50 million unsecured loan agreement with Swedbank, with a 5-year term and interest based on 3-month Euribor plus a margin. The loan will be fully drawn on October 26, 2026, and matures on October 26, 2031. This financi...
AS Tallinna Sadam signed a €50 million unsecured loan agreement with AS Swedbank, maturing in five years with an interest rate based on 3-month Euribor plus margin. The loan, drawn on October 26, 2026, will be used to redeem bonds worth €50.4 million...
Vita Coco, a leading coconut water brand, has partnered with Homesick to create a limited-edition candle collection inspired by Vita Coco Treats flavors: Strawberries & Creme and Frosted Lemonade. The candles capture the essence of these flavors thro...
